Comparative genomics and genome biology of <i>Campylobacter showae</i> by Hsu, Tiffany et al.
 
  
 
Aalborg Universitet
Comparative genomics and genome biology of Campylobacter showae
Hsu, Tiffany; Gemmell, Matthew R; Franzosa, Eric A; Berry, Susan; Mukhopadhya, Indrani;
Hansen, Richard; Michaud, Monia; Nielsen, Hans; Miller, William G; Nielsen, Henrik; Bajaj-
Elliott, Mona; Huttenhower, Curtis; Garrett, Wendy S; Hold, Georgina L
Published in:
Emerging microbes & infections
DOI (link to publication from Publisher):
10.1080/22221751.2019.1622455
Creative Commons License
CC BY 4.0
Publication date:
2019
Document Version
Publisher's PDF, also known as Version of record
Link to publication from Aalborg University
Citation for published version (APA):
Hsu, T., Gemmell, M. R., Franzosa, E. A., Berry, S., Mukhopadhya, I., Hansen, R., Michaud, M., Nielsen, H.,
Miller, W. G., Nielsen, H., Bajaj-Elliott, M., Huttenhower, C., Garrett, W. S., & Hold, G. L. (2019). Comparative
genomics and genome biology of Campylobacter showae. Emerging microbes & infections, 8(1), 827-840.
https://doi.org/10.1080/22221751.2019.1622455
General rights
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners
and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights.
            ? Users may download and print one copy of any publication from the public portal for the purpose of private study or research.
            ? You may not further distribute the material or use it for any profit-making activity or commercial gain
            ? You may freely distribute the URL identifying the publication in the public portal ?
Take down policy
If you believe that this document breaches copyright please contact us at vbn@aub.aau.dk providing details, and we will remove access to
the work immediately and investigate your claim.
Full Terms & Conditions of access and use can be found at
https://www.tandfonline.com/action/journalInformation?journalCode=temi20
Emerging Microbes & Infections
ISSN: (Print) 2222-1751 (Online) Journal homepage: https://www.tandfonline.com/loi/temi20
Comparative genomics and genome biology of
Campylobacter showae
Tiffany Hsu, Matthew R. Gemmell, Eric A. Franzosa, Susan Berry, Indrani
Mukhopadhya, Richard Hansen, Monia Michaud, Hans Nielsen, William G.
Miller, Henrik Nielsen, Mona Bajaj-Elliott, Curtis Huttenhower, Wendy S.
Garrett & Georgina L. Hold
To cite this article: Tiffany Hsu, Matthew R. Gemmell, Eric A. Franzosa, Susan Berry, Indrani
Mukhopadhya, Richard Hansen, Monia Michaud, Hans Nielsen, William G. Miller, Henrik Nielsen,
Mona Bajaj-Elliott, Curtis Huttenhower, Wendy S. Garrett & Georgina L. Hold (2019) Comparative
genomics and genome biology of Campylobacter￿showae, Emerging Microbes & Infections, 8:1,
827-840, DOI: 10.1080/22221751.2019.1622455
To link to this article:  https://doi.org/10.1080/22221751.2019.1622455
© 2019 The Author(s). Published by Informa
UK Limited, trading as Taylor & Francis
Group, on behalf of Shanghai Shangyixun
Cultural Communication Co., Ltd
View supplementary material 
Published online: 06 Jun 2019.
Submit your article to this journal 
Article views: 142
View Crossmark data
Comparative genomics and genome biology of Campylobacter showae
Tiffany Hsua*, Matthew R. Gemmellb, Eric A. Franzosaa, Susan Berryc, Indrani Mukhopadhyac, Richard Hansend,
Monia Michaude, Hans Nielsenf, William G. Millerg, Henrik Nielsenh, Mona Bajaj-Elliotti, Curtis Huttenhowera,
Wendy S. Garrette and Georgina L. Hold a,c,e,j
aDepartment of Biostatistics, Harvard T. H. Chan School of Public Health, Boston, USA; bSchool of Medicine, Medical Sciences and Nutrition,
Centre for Genome Enabled Biology and Medicine, University of Aberdeen, Aberdeen, UK; cSchool of Medicine, Medical Sciences and
Nutrition, GI Research Group, University of Aberdeen, Aberdeen, UK; dDepartment of Paediatric Gastroenterology, Royal Hospital for
Children, Glasgow, UK; eDepartments of Genetics and Complex Diseases and Immunology and Infectious Diseases, Harvard T. H. Chan
School of Public Health, Boston, USA; fDepartment of Clinical Microbiology, Aalborg University Hospital, Aalborg, Denmark; gProduce Safety
and Microbiology Research Unit, U.S. Department of Agriculture, Agricultural Research Service, Albany, USA; hDepartment of Infectious
Diseases, Aalborg University Hospital Aalborg, Denmark; iInfection, Immunity, Inflammation Programme, UCL Great Ormond Street Institute
of Child Health, London, UK; jSt George and Sutherland Clinical School, Microbiome Research Centre, University of New South Wales,
Sydney, Australia
ABSTRACT
Campylobacter showae a bacterium historically linked to gingivitis and periodontitis, has recently been associated with
inflammatory bowel disease and colorectal cancer. Our aim was to generate genome sequences for new clinical
C. showae strains and identify functional properties explaining their pathogenic potential. Eight C. showae genomes
were assessed, four strains isolated from inflamed gut tissues from paediatric Crohn’s disease patients, three strains
from colonic adenomas, and one from a gastroenteritis patient stool. Genome assemblies were analyzed alongside the
only 3 deposited C. showae genomes. The pangenome from these 11 strains consisted of 4686 unique protein
families, and the core genome size was estimated at 1050 ± 15 genes with each new genome contributing an
additional 206 ± 16 genes. Functional assays indicated that colonic strains segregated into 2 groups: adherent/invasive
vs. non-adherent/non-invasive strains. The former possessed Type IV secretion machinery and S-layer proteins, while
the latter contained Cas genes and other CRISPR associated proteins. Comparison of gene profiles with strains in
Human Microbiome Project metagenomes showed that gut-derived isolates share genes specific to tongue dorsum
and supragingival plaque counterparts. Our findings indicate that C. showae strains are phenotypically and genetically
diverse and suggest that secretion systems may play an important role in virulence potential.
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Introduction
Historically, Campylobacter jejuni and Campylobacter
coli have been recognized as intestinal pathogens that
contribute to significant health and economic costs
[1,2]. Recent studies have also found that other Campy-
lobacter species, termed non-jejuni/coli (njc)-campylo-
bacters or “emerging Campylobacter species”, are
associated with a range of diseases, including gastroen-
teritis, periodontitis, inflammatory bowel disease
(IBD), and cancer [3–5]. The prevalence of human ill-
ness associated with emerging Campylobacter species is
currently lower than for C. jejuni and C. coli-associated
illness and are thought to be heavily underreported
[6,7]. One such njc-Campylobacter is Campylobacter
showae, a commensal of the human oral cavity long
linked with periodontal disease [8,9]. It has recently
been associated with inflammatory bowel disease [4,
10–12] and colorectal cancer [5].
C. showae originally formed part of the Campylobac-
ter rectus group until it was formally reclassified by
Etoh et al. in 1993 [8]. C. showae are flagellated, H2S-
producing Gram-negative rods that can grow in micro-
aerophilic or anaerobic conditions but have a require-
ment for fumarate and formate or hydrogen. To date,
little work has been done to characterise pathogenicity
markers in C. showae. Three genomes currently exist: a
closed genome for oral isolate ATCC 51146, also
known as RM3277, along with two draft genome
sequences from colonic tissue isolates. CSUNSWCD
was isolated from a paediatric Crohn’s disease patient
mucosal biopsy [13], while CC57c came from a colonic
tumour specimen [5]. Genomic analyses have indicated
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that the genomes of these two colonic strains are
diverged from ATCC 51146 [5,13] and contain viru-
lence factors that are not detected in this oral strain.
Both CSUNSWCD and CC57c contain components
of a Type IV secretion system, with CSUNSWCD
also shown to contain phage proteins that were not
present in the oral strain. However, both studies were
limited to single strain comparisons to oral strain
ATCC 51146 and, to date, no comparative genomic
analyses have been performed with multiple
C. showae strains.
In this study, we profile the pathogenicity and func-
tionality of 11 C. showae strains using both whole gen-
ome comparisons and experimental approaches. The
strains encompass the three published reference strains
and eight newly-isolated strains from four patients and
were subjected to a combination of Illumina and Pac-
Bio sequencing. We characterized the eight new strains
through experimental assays to assess their ability to
adhere to, invade, and infect host cells and monitored
their response to host colonic tissue explants. We
defined the pan- and accessory genomes of C. showae
using whole genome comparisons and searched for
differences between strains that were adherent/invasive
versus those that were not. Lastly, we describe differ-
ences between oral and colonic strains by comparing
gene family presence/absence between our C. showae
isolates and C. showae within oral metagenomes from
the Human Microbiome Project [14]. Considering
their association with a number of chronic inflamma-
tory diseases, it is important to understand the patho-
genic mechanisms used by C. showae within the gut to
define their impact on human health.
Materials and methods
Bacterial isolates
All bacterial isolates used in the study were obtained
from patient samples. Information on sample types
and disease presentation are shown in Table 1. All
patients gave informed consent, and ethical approval
was obtained from the local ethics committees.
Functional assays
Adherence and invasion
Unless otherwise stated, all bacterial cultures were
grown in Columbia broth (CB) supplemented with
0.2% sodium formate, 0.3% sodium fumarate, and
10% Fetal Calf Serum (FCS) in an anaerobic incubator
at 37°C for 3 days. We assessed the ability of all strains
to adhere to and invade intestinal epithelial cell lines by
conducting gentamicin protection assays with HT-29
epithelial cells (American Type Culture Collection
(ATCC)). We followed the methods of Man et al.
[15] for epithelial cell studies including scanning
electron microscopy, except that we used HT-29 cells
instead of Caco-2 cells.
Bacterial cytotoxicity assay
Bacterial cytotoxicity was assayed by adding bacterial
supernatant extracts to Vero (African green monkey
kidney) tissue culture monolayers. Bacterial super-
natant extracts were prepared by centrifugation (13
000 X g, 5 min) of overnight cultures grown in CB sup-
plemented with 0.2% sodium formate, 0.3% sodium
fumarate, and 10% FCS. Supernatants were filtered
through 0.2 μm membrane filters (Millipore Corpor-
ation, Bedford, MA). Vero cell monolayers were pre-
pared in 96-well microtitre plates (Corning, USA)
with Dulbecco’s Modification of Eagle’s Medium
(DMEM) containing L-glutamine (Gibco Ltd) and
5% Fetal Bovine Serum (FBS), with incubation in 5%
CO2 at 37°C for 24 h. Supernatant filtrates were
added to Vero cells and incubated for 2 days at 5%
CO2 at 37°C; the negative control was phosphate-
buffered saline (PBS). Cells were assessed for cytotox-
icity by looking for rounding of cells.
Galleria mellonella killing assays
G. mellonella larvae (Live Foods) were infected with
C. showae strains in 50 μL inocula (106 CFU of each
C. showae strain) by microinjection in the right foreleg.
The larvae were incubated at 37°C, and survival and
appearance were recorded at 24 h. PBS, media-injected
(CB supplemented with 0.2% sodium formate, 0.3%
sodium fumarate, and 10% FCS) and un-injected con-
trols were also used. Survival 24 h after infection was
recorded. For each experiment, ten G. mellonella larvae
were infected, and experiments were repeated three
times.
Host cytokine secretion
Cytokine secretion of tumour necrosis factor alpha
(TNF-α) and interleukins IL-8 and IL-10 from co-cul-
ture supernatants derived from the human monocytic
leukemia cell line (THP-1; ATCC) was measured as
previously described [16] using a custom-designed
HumanMagnetic Luminex Screening Assay (R&D Sys-
tems, MN, USA) (Supplementary text).
Explant studies
Murine colonic explants were prepared from eight to
twelve-week-old wild-type C57BL/6 mice bred in
house and originally purchased from Jackson Labora-
tory. The colon was resected and flushed with sterile
PBS. The tissue was opened longitudinally and washed
repeatedly with sterile PBS to eliminate the remaining
intestinal content and immediately placed in DMEM
with 10% FCS. The tissues were divided into 5-mm-
long sections under sterile conditions and incubated
at 37°C in humidified 5% CO2 atmosphere. After
10 min, the media was replaced, and the samples
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were incubated for an additional 2 h in the same med-
ium with or without 106 cfu/ml of the various
C. showae strains (grown in Columbia broth (CB) sup-
plemented with 0.2% sodium formate, 0.3% sodium
fumarate, and 10% Fetal Calf Serum (FCS) in an
anaerobic incubator at 37°C for 3 days), before being
harvested and diluted in the DMEM with 10% FCS
and then either snap-frozen in liquid nitrogen for
RNA extraction or fixed overnight in 4% paraformal-
dehyde, followed by routine paraffin embedding, sec-
tioning and staining with H&E.
Biofilm analysis
Biofilm formation was examined during the stationary
culture in vitro in 24-well polystyrene microplates (24
F-Well Microplates, Thermo Fisher Scientific™
Nunc™, Denmark) using a 0.1% crystal violet (CV)
stain as previously described [17]. The media used was
CB supplemented with 0.2% sodium formate, 0.3%
sodium fumarate, and 10% FCS (Supplementary Text).
Expression analysis
Total RNA from bacterial strains and colonic explant
studies were isolated using the RNeasy kit (Qiagen).
cDNAwas prepared from 1 µg of RNA using the Iscript
cDNA synthesis kit (Bio-Rad). Quantitative PCR
(qPCR) was done on a StratageneMX3005P instrument
using the KAPA SYBR Green PCR Kit (Kapa Biosys-
tems). The qPCR primers and efficiencies are shown
in Supplementary Table 1. Relative expression data
were generated using the ddCt method, and corrected
for primer efficiencies according to Pfaffl et al. [18].
Relative expressions from intestinal explants and bac-
terial samples were normalized against the relative
expression of the housekeeping gene glucose-6-isomer-
ase. This was done using the formula Expression(gene of
interest)/Expression(housekeeping gene) = relative expression.
Genome sequencing
We performed short-read sequencing for all eight
strains, of which four (B32_SW, B91_SC, CAM &
129_MSG) were also subjected to long-read sequen-
cing. For sequencing (long and short-read), genomic
DNA was extracted from C. showae liquid cultures as
described previously [19]. Information on de novo
assembly (genomes and plasmids) and gene annotation
can be found in the Supplementary Text file.
Comparative genomics approaches
Determining phylogenetic relationships
A phylogenetic tree based on the assembled genomes of
the Campylobacter showae strains was produced using
REference ALignment based PHYlogenetic builder
(REALPHY) and RAxML (Supplementary Text). The
Campylobacter rectus RM3267 genome was used as
an outgroup for the phylogenetic analysis. REALPHY
aligns genomes to a reference genome/s and uses
aligned sets of orthologous sites (SNPs as well as non-
polymorphic sites) to reconstruct phylogeny. The
number of SNPs detected for each C. showae strain
were similar ranging from 64,703 to 68,264. This analy-
sis was repeated with the strains CSUNSWCD and
B32_SW excluded.
Gubbins was utilized to detect levels of recombina-
tion and to produce phylogenetic tree whilst excluding
areas of recombination [20]. This analysis requires a
reference genome; ATCC 51146 was used as a reference
as it was the most contiguous and complete genome.
BRIG (BLAST Ring Image Generator) was utilized
to create a graphical representation of the similarities
of genomic content within the C. showae genomes
[21]. This requires one genome to be used a reference
to the rest; B32_SW_DW was utilized as the reference,
as it was the largest assembly. Assembled plasmid con-
tigs were BLASTed against each other with BLASTN to
detect similar plasmids across samples.
We used the CLARK sequence classification method
(v1.2.3) with a custom database to classify the strains
B91_SC, B91_SCBr and B91_TPP. CLARK runs were
carried out for each strain using a kmer size of 31
(default). The genomes used within the custom data-
base included multiple Campylobacter genome assem-
blies (see Supplementary Text).
Table 1. C. showae strains characterized in this study.
Strain Patient
Patient
type
Sample
type Diagnosis
Country of
origin
Sequencing
Platform^
Adhesion to colonic
epithelial cells+
Invasion of colonic
epithelial cells*
B32_SW B32 Paediatric Biopsy Crohn’s UK IM + PB 4.85 ± 8.08 0.17 ± 0.03
B91_SC B91 Paediatric Biopsy Crohn’s UK IM + PB 0.15 ± 0.68 0.00 ± 0.00
B91_SCBr B91 Paediatric Biopsy Crohn’s UK IM 0.50 ± 1.08 0.00 ± 0.00
B91_TPP B91 Paediatric Biopsy Crohn’s UK IM 0.27 ± 0.86 0.00 ± 0.00
129_MSG 129 Adult Biopsy Adenoma UK IM + PB 3.42 ± 8.12 0.10 ± 0.01
129_VTPP 129 Adult Biopsy Adenoma UK IM 4.68 ± 9.78 0.13 ± 0.03
129_VTPPs 129 Adult Biopsy Adenoma UK IM 2.45 ± 3.04 0.11 ± 0.01
CAM CAM Adult Stool Gastroenteritis Denmark PB 1.34 ± 2.72 0.33 ± 0.07
Note: All strains’ isolation location was colonic, and all strains were positive in the Vero cell line cytotoxicity assay. Results for adhesion and invasion assays are
mean ± SD of independent experiments.
^IM (Illumina MiSeq), PB (PacBio-RSII).
+Mean number of bacteria ± SD per HT-29 cell after 6 h incubation.
*Mean percentage ± SD of the original inoculum after 1 h gentamicin treatment of 6h-infected HT-29 cells.
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Pangenome generation and exponential decay
calculation
Pan- and accessory genomes were generated for
assembled and reference genomes. We first used
usearch cluster_fast [22] to cluster all Campylobacter
proteins from the CLARK custom database above (n
= 27 902), using a 90% amino acid similarity cut-off,
in order of decreasing length. This resulted in 4686
protein families for our 11 isolates and reference
strains. Protein families were then aligned via DIA-
MOND against the HUMAnN2-formatted UniRef90/
UniRef50 databases [23]. Only protein families that
aligned with ≥90% similarity and ≥80% coverage to a
UniRef90 were annotated (n = 3 514). To determine
which protein families were plasmid-derived, we used
DIAMOND to align the protein families against plas-
mid proteins (which were called by running Prokka
on the plasmid assemblies). Protein families that
aligned to a plasmid protein with ≥90% similarity
and ≥90% coverage were annotated as plasmid-derived
(for the strain the plasmid was from). Of the 4 686
protein families, 524 were from plasmids.
We next estimated the size of the core genome and
calculated the number of new protein families added
per genome. To do this, we generated two datasets.
For the first dataset, we determined the number of
shared protein families between n (1 through 11) gen-
omes in up to 100 combinations, while for the second
dataset, we computed the number of new protein
families with the addition of the nth genome in up to
100 combinations. We fitted each dataset to the expo-
nential decay equation, F(n) = κ × exp(−n/τ) +Ω as
outlined in Tettelin et al. [24]. For the first dataset, Ω
estimates the size of the core genome, while for the
second dataset, Ω estimates the number of new genes
added per genome. The “nls” function in R was used
to fit each dataset to the above equation using starter
values from their paper (κ = 610, τ = 2.16, Ω = 1806).
We then estimated the number of genes in the pangen-
ome using the equation, F(n) =D + (Ω × (n−1)) + (κ ×
exp(−2/τ)) * ((1−exp(−(n−1)/τ))/(1−exp(−1/τ))), in
which D is the average number of genes per sequenced
genome, and κ, τ, and Ω are estimated from the second
dataset (κ = 8201.0209, τ = 0.6778, Ω = 206.0316).
Assessing virulence factors and antibiotic
resistance genes
The Virulence Factor Database (VFDB) and Compre-
hensive Antibiotic Resistance Database (CARD) were
used to detect virulence factors and antibiotic resist-
ance genes in the assembled and annotated chromo-
somes and plasmids (both downloaded September
2016) [25,26]. This was carried out by performing
both nucleotide-nucleotide and protein-protein align-
ments (see Supplementary Text for detail).
Comparison to oral metagenomes
We acquired HUMAnN2 (http://huttenhower.sph.
harvard.edu/humann2) gene family profiles for meta-
genomes from the Human Microbiome Project I
Phase II Project (HMP1-II) [27]. We then filtered for
gene family profiles in which C. showae recruited
reads to (1) ≥500 UniRef90 gene families [28], with
(2) reasonably strong coverage (median non-zero
abundance ≥10 reads per kilobase (RPK), and 3) con-
sistent coverage (3rd quartile / 1st quartile of non-zero
abundances <2.5). This resulted in 64 metagenomes
from the supragingival plaque (n = 43), tongue dorsum
(n = 18), and buccal mucosa (n = 3), respectively.
HUMAnN2 C. showae-specific gene families are
derived from a C. showae pangenome constructed
from isolate genomes RM3277, CSUNSWCD, and
CC57c within MetaPhlAn2 [29]; genes were clustered
at 97% similarity with UCLUST [22]. To compare
our 11 C. showae isolate genomes to the oral metagen-
omes, we aligned each isolate gene to the MetaPhlAn2-
generated pangenome and annotated each gene with a
pangenome element. This allows for standardization of
gene families across metagenomes and isolate genomes.
A file containing the R markdown script for bioin-
formatics analysis and figure generation is supplied in
the Supplementary Information.
Results
Sequencing and assembly of C. showae
genomes
Eight clinical C. showae strains were obtained from
four patients (Table 1). From two children with
newly diagnosed but treatment naive Crohn’s disease
we isolated four strains: a single C. showae isolate
(B32_SW) from one patient, and three C. showae
strains (B91_SC, B91_SCBr and B91_TPP) with differ-
ing colony morphology from the second patient. All
isolates were obtained from inflamed colonic mucosa
[30]. The remaining four strains were isolated from
adults. A single isolate (CAM) was from a patient
with gastroenteritis and three C. showae strains
(129_MSG, 129_VTPP and 129_VTPPs) with differing
morphology were obtained from a patient with a colo-
nic adenoma. CAM was isolated from stool while the
latter three isolates were from the adenoma.
We sequenced seven isolates using Illumina short-
read sequencing and, for the B91_SC, 129_MSG,
CAM and B32_SW isolates, also performed PacBio
RSII long-read sequencing (see Methods). In these
cases, where both the short and long reads were of
sufficient quality (B91_SC, 129_MSG and B32_SW),
we scaffolded short-read assemblies with PacBio sub-
reads to generate more complete assemblies (including
plasmids; see below). The assembled genome for CAM
was derived purely from PacBio long-read sequencing.
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Assemblies contained both chromosomal and plasmid
content; plasmids were separately called and analyzed
later (see below). Quality and completeness of
assembled genomes were estimated, alongside the pub-
licly-available genomes ATCC 51146 (reference oral
strain), CSUNSWCD and CC57c (colonic isolates),
using QUAST, BUSCO, and REAPR [31–33], indicat-
ing high contiguity, high completeness, and low error
for all new genomes (Supplementary Figure 1; Sup-
plementary Table 2 and 3). In each of the resulting
assemblies, only the publicly available CC57c and
CSUNSWCD genomes were demonstrated to have
low levels of completeness. The longest contig for the
CC57c and CSUNSWCD assemblies made up less
than 25% of the assembly length, while the longest con-
tig within all of the new genomes was >57.8% of the
assembly length (Supplementary Figure 1). All gen-
omes were estimated to be >98% complete by
BUSCO, except CC57c and CSUNSWCDwith comple-
teness estimates of 92.9% and 97.6% respectively (Sup-
plementary Figure 1; Supplementary Table 2). All new
genome assemblies had 6 or fewer contigs, while the
existing published colonic strains, CC57c and
CSUNSWCD had 274 and 23 contigs respectively.
Genome sizes ranged from 2.1 Mb to 2.6 Mb with
38–131x Illumina read depth (Supplementary Table
4). One of the new genome assemblies (B91_SC),
which had been subjected to short and long-read
sequencing, yielded a single contig containing all
assembled genome information. The genomes were
analyzed to determine if there was a presence of indels
introduced through sequencing error to a specific
strain. Our isolates showed very similar results to
each other except for 129_VTPP which had more pro-
digal annotated proteins; 1389 compared to the range
of 1150–1243 for the other isolates (Supplementary
Table 5). The publically available samples (CC57,
ATCC 51146, and CSUNSWCD) were also similar
but of slightly lower quality.
Genome analysis identifies heterogeneity in
phylogenetic relationships and genome
structure between C. showae strains
The genomes of the 11 C. showae strains were com-
pared using BRIG (Figure 1(A)), and a phylogenetic
analysis was performed using whole-genome-sequence
alignments with the C. rectus RM3267 genome as the
outgroup (Figure 1(B)). The three C. showae strains
isolated from patient 129 were almost identical (Figure
1(B)). Isolate B32_SW appeared most closely related to
the paediatric colonic strain, CSUNSWCD, with these
five strains forming a clade. In contrast, CAM did
not cluster particularly with any other C. showae
strains. Its closest relatives were the oral strain ATCC
51146 and the colonic tumour isolate CC57c. The
three strains from paediatric patient B91 are almost
identical but did not form a monophyletic clade with
the other C. showae strains and were most closely
related to C. rectus. To confirm whether the B91 strains
were indeed C. showae, we used CLARK to classify the
genome assemblies with a custom database of Campy-
lobacter species genomes. All the B91 strains were
classified as C. showae, with only very small scaffolds
(<1500 bp and one scaffold of B91_TPP (12,505 bp))
Figure 1. Genome assemblies of eight newly-characterized C. showae strains. (A) BRIG (BLAST Ring Image Generator) [21] showing
the assembled genomes aligned to the longest genome (B32_SW). KEGG BRITE [58] functional categories are annotated on the
image to indicate where they are located within the genome, and strains are denoted by colors shown on the (B) phylogenetic
tree (whole genome alignment, generalized time reversible model; see Methods). Bootstrap values are shown at each node. (C)
Estimated number of core, new, and pan-genes within the C. showae clade with fits calculated using an exponential decay model.
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being classified as other Campylobacter species or not
at all (Supplementary Table 6).
Homologous recombination plays a large role for
adaptation for C. jejuni [34]. We assessed the extent
of horizontal sequence transfer within the C. showae
strains using the ATCC 51146 strain as a reference. A
phylogenetic tree excluding predicted regions of hori-
zontal gene transfer was produced with the level of
recombination across the genomes shown (Sup-
plementary Figure 2A). This phylogeny was highly
similar to that of the whole genome (Figure 1(B)),
with two main differences. First, CC57c and ATCC
51146 do not form a monophyletic clade, and second,
CAM and the B91 strains (B91_SC, B91_SCBr &
B91_TPP) did not form a monophyletic clade in the
recombination excluded phylogeny.
The degree of predicted recombination varies widely
across the C. showae strains; however, the predicted
recombination regions are shared within the (1) 129
clade and within the (2) B91 and CAM clade. The high-
est levels of recombination were detected in the strains
B32_SW and CSUNSWCD, with 225 and 170 recombi-
nation blocks, respectively, spanning >500,000 bases
each (Supplementary Table 7). In contrast, the recom-
bination areas in all other strains comprised <100,000
bases. The 129 strains (129_VTPP, 129_VTPPs &
129_MSG) contained 74,770–78,938 bases in recombi-
nation areas, of which the vast majority was shared
between the three strains. ATCC 51146 & CC57c con-
tained 10,961 & 15,975 bases in recombination areas,
respectively. The B91 strains (B91_SC, B91_SCBr &
B91_TPP) & CAM contained the lowest levels of
recombination with 4388–4584 bases in recombina-
tion, which were also largely shared.
Phylogeny reconstruction of the whole genomes
with REALPHY was repeated without CSUNSWCD
and B32 SW (Supplementary Figure 2B), the two
strains with the highest recombination, which resulted
in a tree highly similar to the original (Figure 1(B)) Like
the phylogeny without recombination (Supplementary
Figure 2(B)), ATCC 51146 and CC57c did not form a
monophyletic clade.
We next quantified the size of the C. showae pangen-
ome within these new isolates and reference genomes.
To do so, we annotated the genomes using Prokka, clus-
tered protein sequences at 90% amino acid similarity,
Figure 2. Colonic C. showae strains demonstrate a range of virulence potential. (A) Adhesion to HT29 colonic epithelial cells with
SEM. For images within inset: B32_SW- (top) and CAM-infected (bottom) cells. (B) and (C) Galleria mellonella killing. Groups of 10
larvae were used and the results shown are the means of three experiments recorded 24 h after challenge. Error bars indicate stan-
dard errors of the mean. *P < 0.05 (survival compared with C. jejuni; Welch-corrected 2-tailed t tests for pooled data from three
separate experiments). (D) Evidence of biofilm formation in isolate B91_SC. Results shown are the means of three independent
experiments recorded 24 h after inoculation. Error bars indicate standard errors of the mean. (E) Cytokine production from
THP1-cells. Error bars indicate standard errors of the mean.
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and annotated the resulting families with UniRef90
identifiers. Of the 4 686 protein families, the core gen-
ome (protein families shared by all isolates) comprised
1 260 families, the accessory genome (protein families
shared between two or more strains) included 1 881
families, and unique proteins (protein families unique
to 1 strain) consisted of 1 545 families (Supplementary
Figure 3, Supplemental Table 8). Core proteins included
DNA polymerases I and III, along with known Campy-
lobacter speciesmarkers, such as the flagellar genes flgG,
flhA, flhF, flhB, fliP, fliR and fliS. C. showae requires
fumarate and formate for growth [8], and we observed
genes for fumarate metabolism (e.g. genes encoding the
three subunit fumarate reductase FrdABC) and genes
for formate metabolism (formate dehydrogenase, for-
mate hydrogenlyase, and formate-tetrahydrofolate
ligase) (Supplemental Table 8). 98.96% of the unique
protein families belonged to five strains: CC57c (n =
387), CAM (n = 478), B32_SW (n = 265), ATCC
51146 (n = 244) and CSUNSWCD (n = 155) (Sup-
plementary Figure 3). The six remaining genomes had
genes encoding seven or fewer unique proteins, reflect-
ing the high degree of similarity within the three strains
from patient B91 and the three strains from patient 129.
Using an exponential decay function [24,35], we esti-
mated the C. showae core genome to be 1 284 ± 7
genes and that each new genome added an additional
200 ± 14 genes. For comparison, Streptococcus agalac-
tiae and Escherichia coli are estimated to have core gen-
omes of 1 806 and 2 200 genes, respectively, and
relatively large pangenomes (each genome adds
approximately 33 and 300 genes, respectively) (Figure
1(C)).
Using IslandViewer [36], we detected significant
genomic islands within all genomes, suggesting that
the C. showae genome has undergone horizontal gene
transfer (Supplemental Table 9). We were able to ident-
ify a number of predicted genomic islands in each gen-
ome and performed PCR validation of several
prophage clusters, which confirmed the presence of
the various transposases and integrases.
Functional assessment of virulence and
pathogenic potential of C. showae strains
Since these strains were isolated from patients, we
profiled strain characteristics such as the ability to (i)
adhere to and invade epithelial cells (Table 1), (ii)
secrete virulence factors, and (iii) infect larvae of the
greater wax moth Galleria mellonella. First, we
observed that the adherence level of the C. showae
strains to HT29 colonic epithelial cells ranged from
0.15 to 4.85 bacterial cells per epithelial cell (average
of 100 epithelial cells counted per strain/per exper-
iment; three independent experiments; Figure 2(A);
Table 1). The three strains from patient B91 showed lit-
tle evidence of adherence (average of 0.3 bacterial cells
per epithelial cell), while the remaining five strains all
showed adherence levels of >3.3 bacterial cells per epi-
thelial cell (Table 1). The various adherent strains
induced varying levels of cell damage (Figure 2(A)),
with strain B32SW causing limited cell damage, whilst
CAM strain caused extensive membrane blebbing and
cell ultimately cell death. These five strains (129_MSG,
129_VTPP, 129_VTPPs, CAM, B32_SW) were also
invasive, with invasion levels of HT-29 colonic epi-
thelial cells ranging from 0.10% to 0.33% (Table 1),
where a reference positive control strain of Salmonella
enterica Serovar typhi had an invasion level of 20.3% ±
1.45% (data not shown). None of the strains could
invade macrophages, although incubation of the
C. showae strains with the THP-1 human monocytic
leukemia cell line for 6 h led to proinflammatory cyto-
kine production (TNF-α, IL-1b and IL-8) (Figure 2(E)).
Second, we assessed the presence of secreted virulence
factors by inoculating C. showae supernatants onto
Vero cells. All culture supernatants demonstrated cyto-
toxic activity by increasing the size and rounding of
Vero cells. Third, we assayed each strain’s ability to
infect Galleria mellonella larvae, which are susceptible
to infection by a number of bacterial pathogens includ-
ing C. jejuni [37]. All larvae challenged with PBS or cul-
ture media and uninfected controls were alive after
24 h (Figure 2(B and C)). Larvae challenged with
C. jejuni (106 CFU) had approximately 70% survival;
however, larvae challenged with C. showae (106 CFU)
had <10% survival. We also looked at whether
C. showae strains were able to form biofilms, as several
studies have shown that biofilms play a key role in bac-
terial colonization of the healthy gut and in intestinal
diseases [38]. Bacteria growing in biofilms are also
known to express increased virulence traits or
increased resistance to antibiotics or host defense
measures [39,40]. Strain B91_SC showed evidence of
biofilm formation, which was not demonstrated by
the other ten C. showae strains (Figure 2(D)).
To understand how C. showae may behave within
the gut, we cultured C. showae strains in the presence
of murine large intestinal segments. Histology-based
assessment indicated that colonic explants remained
intact during the incubation period (2 hrs), however,
C. showae strains caused dramatic loss of tissue archi-
tecture and integrity (Figure 3(A)). Microbiological
analysis indicated that the C. showae cells remained
viable during the incubation (on average ∼65% com-
pared to initial counts, Figure 3(B)). All C. showae
strains induced damage to colonic explant integrity.
Real-time quantitative PCR (RTqPCR) analysis
showed that C. showae virulence gene expression levels
differ across strains and may change when in contact
with colonic tissue. All strains except B91_SC had
decreased expression of pomA (a motor protein
involved in chemotaxis) when in contact with the colo-
nic explant. 129_MSG, 129_VTPP, and B32_SW had
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higher expression of hlyD (involved in haemolysin
secretion), accA (involved in lipid metabolism), and
flaB (a non-essential flagellin protein) as compared to
B91_SC and CAM (whether alone or with the colonic
explant). In contrast, strains B91_SC and CAM had
higher expression for tonB (involved in iron transport)
and hopAH-2 (part of the type III secretion system)
relative to the other strains (whether alone or with
the colonic explant). Strain 129_MSG showed
increased expression for all three genes when inocu-
lated with the colonic explant, while CAM showed
decreased tonB expression and increased hopAH-2
expression with the explant (Figure 3(C)).
The differential expression of these genes in the
presence of the colonic explant may elucidate host
protein alignments (see Supplementary Text for detail).
Comparison to oral pathogen interactions. Chemo-
taxis allows bacteria to swim towards or away from
specific niches, and is utilized by a number of patho-
genic bacteria, including Helicobacter pylori [41].
pomA expression in C. showae strains may decrease
upon contact with the host as an energy conservation
mechanism. The high expression of flaB in the adher-
ent/invasive strains (129_VTPP, B32_SW, and
129_MSG) suggest an adjustment to growth conditions
[42,43] or pathogenesis, as C. jejuni employs flagellar
genes for secretion of non-flagellar proteins that modu-
late virulence [44]. Decreased expression of tonB along
with upregulation of the type III secretion system may
indicate how B91_SC and CAM derive metabolites
from the host. This activation is in line with other
Gram-negative bacterial systems, in which secretion
systems (particularly Type III) are activated by bac-
terial contact with host cell surfaces [45]. CAM, an
invasive strain, has similar gene expression patterns
across all six genes when compared to B91_SC, a
non-invasive and non-adherent strain. Together,
these findings show that all of our C. showae strains
are cytotoxic and infect G. mellonella; interestingly,
the B91 strains are not adherent or invasive to epi-
thelial cells, and strains vary widely in expression
profiles when in contact with the host.
Genomic differences between adherent/invasive
C. showae isolate strains
We next searched the pangenome for genetic and func-
tional elements that might explain the differences
between invasive/adherent strains (129_MSG,
129_VTPP, 129_VTPPs, CAM, B32_SW) and the
Figure 3. Campylobacter showae promotes loss of tissue architecture and exhibits altered pathogenicity in the host intestine. (A)
Light micrograph of hematoxylin & eosin-stained formalin-fixed paraffin- embedded colonic tissue from C57BL/6J mouse colon
explant co-cultures. (B) viability of C. showae strains following 2 hr explant co-culture. (C) RTqPCR analysis of a selection of
C. showae virulence/pathogenicity genes in 2 hr pure culture and following 2 hr explant co-culture. Data are represented as
mean ± SEM.
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non-invasive/non-adherent strains (those from patient
B91) (Figure 4). The invasive/adherent strains con-
tained Type IV secretion system (T4SS) and S-layer
proteins, while non-invasive/non-adherent strains con-
tained filamentous hemagglutinin, CRISPR, and
repeats-in-toxin (RTX) proteins. We further assembled
plasmids (Supplemental Table 10, Supplemental Table
11) and determined whether protein families were
chromosomal or plasmid-borne. The presence of
T4SSs exclusively in invasive/adherent strains clearly
highlights differences in virulence traits between the
strains. T4SSs generally mediate the contact-dependent
transfer of DNA and protein substrates from bacteria
to recipient hosts [46]. For example, in the H. pylori
Cag-T4SS, host and environmental conditions (such
as iron limitation) cause increased pili formation and
translocation of the effector protein (cagA) into host
cells via the T4SS [47]. For our isolates, all strains con-
tained pilZ and 5 strains had pilT, which may be
involved in type IV pilus assembly [48] or twitching
mobility, respectively. The presence of pilus-related
genes in C. showae is remarkable in itself, as its pres-
ence in C. jejuni has been controversial. Pili have
been observed via electron microscopy but not tied to
pili genes [49]. This observation of pili was refuted sev-
eral years later [50] and subsequently regarded as an
artifact attributable to the culture broth. We observed
that multiple components of the T4SS were plasmid-
derived for the strains from patient 129, B32_SW,
and CC57c, but notably not CSUNSWCD.
Other proteins present only in the adherent/inva-
sive strains included S-layer proteins, which again
highlights the heterogeneity of virulence mechanisms
exhibited by C. showae. S-layer proteins are capsule-
like assemblages present on the cell surface of sev-
eral Gram-negative pathogens including Campylo-
bacter fetus and C. rectus [51]. They play a role in
immune avoidance, in which they confer resistance
to complement-mediated killing and cause down-
regulation of pro-inflammatory cytokine levels. To
date, in-depth analysis of S-layer protein compo-
sition of C. fetus and C. rectus strains has not
been carried out, although it is recognized that S-
layer composition in these pathogenic strains is sub-
ject to high frequency antigenic variation. In the
C. showae analysis, four different S-layer protein
families were found to be plasmid-derived for
129_VTPPs and are likely present on the chromo-
some in the other strains.
Proteins present only in the non-adherent/non-
invasive strains included filamentous hemagglutinins,
Cas and other CRISPR-associated proteins, and RTX
toxins. None of these proteins were found on plasmids,
other than the filamentous hemagglutinin transporter
precursor protein FhaC. Filamentous hemagglutin
has been used for adhesion in Bordetella pertussis but
may also be used for iron acquisition [52]. CRISPR
loci are found in certain bacteria where they confer
resistance to exogenous genetic elements [53].
CRISPR-associated genes were found in the three
strains from patient B91, CAM, CC57c, and ATCC
51146. They shared the CRISPR-associated endonu-
clease genes cas1 and cas2, but only some strains
encoded the helicase Cas3 and only the latter two
strains encoded Cas5. To extend our understanding
of CRISPR-Cas variation between isolates, we analyzed
spacer content in the CRISPR positive strains using
CRISPRCasFinder. We confirmed CRISPR-Cas sys-
tems in all of the above strains except CC57c, most
being of type IB (Supplementary Figure 4; Supplemen-
tary Table 12). Absence of CRISPR-Cas systems has
been associated with microbes that have obligate sym-
biotic lifestyles (as opposed to those with free-living
lifestyles), since CRISPR arrays may increase the risk
of acquiring spacers that target the host [54]. Lastly,
the RTX toxins are virulence factors made by Gram-
negative bacteria and may consist of either hemolysins
or leukotoxins. In our study, hemolysins and leukotox-
ins were found only in the three strains from patient
B91 and in CC57c. The presence of different toxins
in adherent/invasive versus non-adherent/non-inva-
sive strains may indicate varying virulence methods
even within the same species.
Virulence and antibiotic resistance profiling
We searched for virulence factors and antibiotic resist-
ance genes by aligning all isolate proteins against the
Virulence Factor Database (VFDB) (via BLASTP)
and the Comprehensive Antibiotic Resistance Database
(CARD) (via RGI) [25,26]. Our C. showae isolates
aligned poorly to both reference databases, indicating
that C. showae is distantly related generally to more-
characterized pathogens (Supplementary Table 5).
CARD identified 66 potential antibiotic resistance
genes (ARGs) passing a 80% coverage threshold in
C. jejuni, but only 5–9 ARGs among C. showae strains.
Whilst our C. showae strains had 95–107 VFDB hits
with >50 bitscore and 59–75 CARD hits with >50 bit-
score the reference C. jejuni (NCTC 11168) had 157
VFDB hits with >50 bitscore and 1430 CARD hits
with >50 bitscore. Furthermore, VFDB Our VFDB
search against our C. showae strains and the C. jejuni
reference detected a total of 170144 different virulence
factors passing an 80% coverage threshold in C. jejuni,
and 84–91 virulence factors in the C. showae strains 66
of these were only found only in the C. jejuni reference
and 26 were not detected in the C. jejuni reference
(Supplementary Figure 6).
Like C. jejuni, these proteins included 35 flagella-
related proteins and 9 proteins related to pseudami-
nic acid synthesis. We also found adherence-related
proteins, such as: the capsular proteins KpsF and
CpsA; lipooligosaccharide proteins GmhA, GmhB,
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WaaC, HtrB and HldE; the invasion antigen CiaB
(but not CiaC which requires a Type III secretion
system); and the outer membrane fibronectin-binding
protein CadF. The latter has been found to be essen-
tial for C. jejuni binding to INT 407 cells [55]. Some
proteins distinguished between groups of strains: the
adherent/invasive strains from patient 129 contained
the HhuA haemoglobin-haptoglobin binding protein
and shared the T4SS with CC57c, CSUNSWCD,
B32_SW, and CAM, while the non-adherent/non-
invasive B91 strains and CC57c carried capsule pro-
teins Cap8O and Cps4l, that were not identified in
the patient 129 strains. To determine which virulence
factors were plasmid-derived, we aligned all plasmid
proteins against VFDB (Supplementary Figure 6).
We again detected the T4SS, as well as capsule
genes kpsF and cpsF. We further identified urease-
related genes ureB and ureG (which are similar to
those of Helicobacter) and the tviB antigen; B91_SC
and B91_TPP strains contained RNA polymerase fac-
tor sigma-54, which plays a role in regulation of flaB
expression and host colonization in C. jejuni [42].
For antibiotic resistance, we identified inner mem-
brane transporters AcrF and MexQ, as well as the
membrane fusion protein CmeA in all strains. MacA
and MacB were encoded by all strains, except that
the latter was not encoded by CC57c. Together, these
two proteins form an antibiotic efflux complex with
TolC, which was not present in any strain [56] (Sup-
plementary Figure 5). No plasmid-borne antibiotic
resistance genes were identified. Overall, antibiotic
resistance genes were rare and difficult to detect, and
C. showae only contains a subset of the virulence
genes present in C. jejuni.
Figure 4. Gene families, including T4SS, virulence factors, and CRISPR-Cas systems, differ in adherent/invasive C. showae strains. (A)
Gene families that differ in their presence/absence among C. showae isolates. A subset of genes of interest are labelled with Prokka
and UniRef90 annotations when available. Isolates are clustered based on “Euclidean” distances using “complete” method. (B) We
searched for Type IV secretion proteins in each C. showae genome, which are displayed here by position and direction based on
Prokka annotations.
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Gene families within gut-derived C. showae
isolates segregate with oral metagenomes,
based on location
C. showae is indigenous to the human oral cavity, but
all strains isolated in this study were from the colon
or stool (Table 1). To better understand how the colo-
nic C. showae strains may differ from oral strains, we
compared gene family presence/absence in our
C. showae genomes to C. showae in metagenomes
from the expanded Human Microbiome Project
(HMP1-II) [27]. To do this, we examined HUMAnN2
(http://huttenhower.sph.harvard.edu/humann2) gene
family profiles for HMP1-II metagenomes where
C. showae recruited reads to (1) ≥500 UniRef90 gene
families, with (2) reasonably strong and consistent cov-
erage (see Methods). This included 64 oral metagen-
omes in which C. showae contained on average
0.495%, 0.662%, and 0.468% abundances in supragin-
gival plaque (n = 43), tongue dorsum (n = 18), and buc-
cal mucosa (n = 3), respectively. Unfortunately, this
filtered out all gut metagenomes, but included 64 oral
metagenomes in which C. showae contained on aver-
age 0.495%, 0.662%, and 0.468% abundances in supra-
gingival plaque (n = 43), tongue dorsum (n = 18), and
buccal mucosa (n = 3), respectively. To make the isolate
genomes more comparable to the metagenomes, we
aligned each isolate gene to HUMAnN2 C. showae-
specific gene families and annotated them with the
top match. A total of 3 981 UniRef90 gene families
were present across all metagenomes and genomes,
and 1 936 had non-trivial annotations. 123 were
found only in the metagenomes, with 27 found exclu-
sively in the genomes (Supplemental Figure 7).
We first reviewed whether protein families that were
differential between adherent/invasive and non-adher-
ent/non-invasive strains were also found in the oral
metagenomes. We were unable to detect filamentous
hemagglutinin with this method of gene annotation,
but observed that the T4SS, S-layer proteins, the hemo-
globin and hemoglobin-haptoglobin-binding protein B
(identified via VFDB), and CRISPR proteins were pre-
sent across a majority of tongue dorsum and supragin-
gival plaque metagenomes (Supplemental Table 13).
The RTX protein and four hemolysin-type calcium
binding domain proteins were unique to CC57c and
relatively rare across oral metagenomes. The former
was present in 2 tongue dorsum and 15 supragingival
plaque metagenomes, while the latter four were
found in only 0–2 tongue dorsum and 1–13 supragin-
gival plaque metagenomes. In contrast, a putative
Figure 5. C. showae gut isolate strains differ in their functional capacity from strains observed in oral metagenomes. Data show
gene families with informative UniRef90 annotations were contained in this study’s isolates or in at least 75% of supragingival pla-
que metagenomes and less than 25% in tongue dorsum metagenomes from the Human Microbiome Project (or vice-versa). Cluster-
ing is by Jaccard distance.
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hemolysin was found in CC57c, CAM, the three strains
from patient B91, in all 43 supragingival plaque meta-
genomes and in 11 of 18 tongue dorsum metagenomes.
We next looked to see whether colonic strains might
preferentially share genes with C. showaemetagenomes
from the tongue dorsum, supragingival plaque, or
neither body site (Supplemental Figure 7). Strains
from patient 129, B32_SW, and CSUNSWCD con-
tained multiple genes seen in a majority of tongue dor-
sum metagenomes and a minority of supragingival
plaque metagenomes while strains from patients B91
and CC57c carried genes with the opposite pattern
(Figure 5). The former contained genes for a periplas-
mic protein, motility membrane protein, and phospho-
glycolate phosphatase while the latter had several
methyl-accepting chemotaxis proteins, UDP-N-acetyl-
glucosamine enzymes, and Type II and III secretion
system proteins. Lastly, the prepilin-type cleavage/
methylation N-terminal proteins were prevalent across
oral metagenomes and present only in CC57c and in
oral strain ATCC 51146. Genes with this pattern may
be specific to oral strains and eventually lost in strains
that adapt to persistence (or pathogenicity) in the gut.
Prepilin-like proteins are often used to form type IV
pili and biofilms, and they are also necessary for
enzyme and toxin secretion [57].
Discussion and conclusion
Here, a combination of experimental characterization
and comparative genomics shows that the emerging
intestinal pathogenic species Campylobacter showae
exhibits a range of phenotypes explained by differences
in the presence/absence of variety of gene families.
Notably, strains from one patient (129) are adherent/
invasive, whereas those from patient B91 are not.
This may result from their different hosts and diag-
noses; the former is from an adult patient with colonic
adenoma, while the latter is derived from a pediatric
patient with Crohn’s disease. The B32_SW strain is
also from a pediatric patient with Crohn’s disease, yet
shows more phenotypic and genomic similarity to
the strains from patient 129. This suggests that the pan-
genomic diversity of C. showae can have clinical conse-
quences for its hosts, potentially necessitating more
careful management of infections. Some observed
gene differences, such as that of the T4SS, clearly segre-
gates with adherent/invasive phenotypes, while genes
such as methyl-accepting chemotaxis proteins are pri-
marily found in supragingival plaque metagenomes.
Still, the majority of gene families have no meaningful
annotation or match with databases VFDB and CARD,
indicating that the current mechanistic characteriz-
ation of C. showae remains incomplete. By combining
functional assessments with genome comparisons, our
study significantly adds to the current knowledge base
and contributes to our understanding of the evolution
and adaptation of bacterial virulence of C. showae in
the gut environment.
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